Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 20, 2020

Primary Completion Date

July 20, 2020

Study Completion Date

July 20, 2020

Conditions
COVID-19Myocardial InjuryMyocarditis
Interventions
DIAGNOSTIC_TEST

Electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care

"* 12 derivations electrocardiogram done at baseline and repeated every 3 days~* transthoracic echocardiography at baseline~* clinical features at baseline: WHO performans status comorbidities and treatments~* biological results in routine care, such as baseline full blood count, inflammation markers: C-reactive protein, procalcitonin, interleukin-6 and ferritin, coagulation and troponin and brain natriuretic peptide"

Trial Locations (1)

75013

Clinical Investigation Center Pitié-Salpêtrière, Paris

All Listed Sponsors
lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT04320017 - Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 | Biotech Hunter | Biotech Hunter